COMBINATION CONTAINING TWO NICOTINE-CONTAINING DRUGS FOR THE TREATMENT OF COVID-19

摘要

The invention relates to a combination of at least two drugs for use in the prevention and/or treatment of Covid-19, the first drugs as well as the second drug containing nicotine and/or one or more pharmaceutically active salts thereof as the active ingredient and the dosage form of the first drug differing from the dosage form of the second drug.